Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Major Insider Selling Witnessed At Examworks Group, Inc. (EXAM) And Isle of Capri Casinos (ISLE)

Page 1 of 2

Whenever markets are gripped by volatility, a lot of investors panic, and insiders are no different. Though insider selling isn’t always due to a bearish outlook on the stock or because of external market factors, it can sometimes be the case that insiders are selling for one of these reasons, particularly if they feel the value of their holdings will fall dramatically, whether they believe it’s actually deserved or not. In the last 15 days or so, numerous stocks have witnessed aggressive selling, however, there are two stocks that have caught our attention recently, as even though they haven’t fallen much in the past two weeks in comparison to other stocks, they have witnessed notable insider selling. In this article we are going to focus on them, and they are Isle of Capri Casinos (NASDAQ:ISLE), and Examworks Group, Inc. (NYSE:EXAM).

Insider Trading 3

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 118% over the ensuing 36 months, outperforming the S&P 500 Index by over 60 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Montana-based casino operator Isle of Capri Casinos (NASDAQ:ISLE) has turned out to be an outlier this year, being one of the few industry stocks that has more than doubled, which perhaps explains the insider selling of it. On September 4, Lee Wielansky, an Independent Director of the company disposed of 20,000 shares at a weighted average price of $19.11 per share. Following this transaction, Mr. Wielansky now owns 79,779 shares of Isle of Capri Casinos. The company announced in August that it will be closing its casino at Natchez, which is one of the oldest casinos in the state of Mississippi. More recently, shares of Isle of Capri Casinos climbed by over 10% on September 2 after the company released its fiscal first quarter of 2016 earnings after the market closed on September 1. EPS for the quarter came in at $0.28, compared to analysts’ consensus estimate of $0.17. Following the earnings declaration, analysts at Macquarie reiterated their ‘Outperform’ rating on the stock on September 3, while upping their price target to $23 from $20, which represents a potential upside of around 19%. During the second quarter, Jim Simons‘ Renaissance Technologies almost doubled its stake in Isle of Capri Casinos (NASDAQ:ISLE) to 830,023 shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!